{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:22:17Z","timestamp":1788056537050,"version":"build-2784847793"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00210-024-03420-0","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T13:02:37Z","timestamp":1727701357000},"page":"3093-3101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bioavailability enhancement of atazanavir sulphate using mixed micelles: in vitro characterization and in vivo pharmacokinetic study"],"prefix":"10.1007","volume":"398","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9414-204X","authenticated-orcid":false,"given":"Nidhi","family":"Pandya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6062-5799","authenticated-orcid":false,"given":"Prabha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"issue":"20","key":"3420_CR1","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.3390\/molecules25204707","volume":"25","author":"MC Bergonzi","year":"2020","unstructured":"Bergonzi MC, Vasarri M, Marroncini G, Barletta E, Degl\u2019Innocenti D (2020) Thymoquinone-loaded Soluplus\u00ae-Solutol\u00ae HS15 mixed micelles: preparation, in vitro characterization, and effect on the SH-SY5Y cell Migration. Molecules. 25(20):4707. https:\/\/doi.org\/10.3390\/molecules25204707","journal-title":"Molecules."},{"key":"3420_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1155\/2012\/916573","volume":"2012","author":"AM Butt","year":"2012","unstructured":"Butt AM, Amin MCIM, Katas H et al (2012a) In vitro characterization of Pluronic F127 and D-\u03b1-tocopheryl polyethylene glycol 1000 succinate mixed micelles as nanocarriers for targeted anticancerdrug delivery. J Nanomater 2012:112","journal-title":"J Nanomater"},{"key":"3420_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1155\/2012\/916573","volume":"2","author":"AM Butt","year":"2012","unstructured":"Butt AM, Mohd HK, Benjakul R (2012b) In vitro characterization of Pluronic F127 and d\u2013tocopheryl polyethylene glycol 1000 succinate mixed. J Nanomater 2:11. https:\/\/doi.org\/10.1155\/2012\/916573","journal-title":"J Nanomater"},{"key":"3420_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/J.EJPB.2018.06.002","volume":"138","author":"S Cao","year":"2019","unstructured":"Cao S, Woodrow KA (2019) Nanotechnology approaches to eradicating HIV reservoirs. Eur J Pharm Biopharm 138:48\u201363. https:\/\/doi.org\/10.1016\/J.EJPB.2018.06.002","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"3420_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ejpb.2007.11.021","volume":"69","author":"DA Chiappetta","year":"2008","unstructured":"Chiappetta DA, Degrossi J, Teves S et al (2008) Triclosanloaded poloxamine micelles for enhanced topical antibacterial activity against biofilm. Eur J Pharm Biopharm 69(2):535\u2013545","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"3420_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2217\/nnm.12.104","volume":"8","author":"DA Chiappetta","year":"2013","unstructured":"Chiappetta DA, Hocht C, Opezzo JA et al (2013) Intranasal administration of antiretroviral-loaded micelles for anatomical targeting to the brain in HIV. Nanomedicine 8(2):223\u2013237","journal-title":"Nanomedicine"},{"issue":"4\u20135","key":"3420_CR7","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/J.ADDR.2009.11.017","volume":"62","author":"J das Neves","year":"2010","unstructured":"das Neves J, Amiji MM, Bahia MF, Sarmento B (2010) Nanotechnology-based systems for the treatment and prevention of HIV\/AIDS. Adv Drug Deliv Rev. 62(4\u20135):458\u2013477. https:\/\/doi.org\/10.1016\/J.ADDR.2009.11.017","journal-title":"Adv Drug Deliv Rev."},{"key":"3420_CR8","doi-asserted-by":"publisher","unstructured":"Ding Y, Wang C, Wang Y, Xu Y, Zhao J, Gao M, \u2026 Li L (2018) Development and evaluation of a novel drug delivery: Soluplus\u00ae\/TPGS mixed micelles loaded with piperine in vitro and in vivo. Drug Dev Ind Pharm 44(9):1409\u20131416. https:\/\/doi.org\/10.1080\/03639045.2018.1472277","DOI":"10.1080\/03639045.2018.1472277"},{"key":"3420_CR9","unstructured":"European Medicines Agency (2003)\u00a0ICH Topic Q 1 a (R2) Stability testing of new drug substances and products step 5 note for guidance on stability testing: stability testing of new drug substances and products"},{"key":"3420_CR10","unstructured":"Global HIV Programme (2022) https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics. Accessed 9 May 2022"},{"key":"3420_CR11","unstructured":"HIV\/AIDS (2022) https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids. Accessed 18 May 2022"},{"issue":"2","key":"3420_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0168-3659(02)00009-3","volume":"82","author":"AV Kabanov","year":"2002","unstructured":"Kabanov AV, Batrakova EV, Alakhov VY (2002) Pluronic\u00ae block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 82(2):189\u2013212","journal-title":"J Control Release"},{"issue":"2","key":"3420_CR13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/J.PROGPOLYMSCI.2013.07.005","volume":"39","author":"P Kesharwani","year":"2014","unstructured":"Kesharwani P, Jain K, Jain NK (2014) Dendrimer as nanocarrier for drug delivery. Prog Polym Sci 39(2):268\u2013307. https:\/\/doi.org\/10.1016\/J.PROGPOLYMSCI.2013.07.005","journal-title":"Prog Polym Sci"},{"issue":"5","key":"3420_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3109\/03639045.2010.533276","volume":"37","author":"H Liang","year":"2011","unstructured":"Liang H, Yang Q, Deng L et al (2011) Phospholipid\u2013tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel. Drug Dev Ind Pharm 37(5):597\u2013605","journal-title":"Drug Dev Ind Pharm"},{"key":"3420_CR15","first-page":"559","volume":"7","author":"Y Ma","year":"2012","unstructured":"Ma Y, Zhao X, Li J et al (2012) The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability. Int J Nanomedicine 7:559","journal-title":"Int J Nanomedicine"},{"key":"3420_CR16","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.ijbiomac.2015.09.053","volume":"82","author":"HS Mahajan","year":"2016","unstructured":"Mahajan HS, Mahajan PR (2016) Development of grafted xyloglucan micelles for pulmonary delivery of curcumin: in vitro and in vivo studies. Int J Biol Macromol 82:621\u2013627","journal-title":"Int J Biol Macromol"},{"key":"3420_CR17","first-page":"117","volume":"4","author":"OO Oguntibeju","year":"2012","unstructured":"Oguntibeju OO (2012) Quality of life of people living with HIV and AIDS and antiretroviral therapy. HIV AIDS (Auckl) 4:117","journal-title":"HIV AIDS (Auckl)"},{"issue":"3","key":"3420_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1345\/aph.18089","volume":"33","author":"VB Pai","year":"1999","unstructured":"Pai VB, Nahata MC (1999) Nelfinavir mesylate: a protease inhibitor. Ann Pharmacother 33(3):325\u2013339","journal-title":"Ann Pharmacother"},{"key":"3420_CR19","doi-asserted-by":"crossref","unstructured":"Patil P, Mahajan H (2018) Mixed micelles for bioavailability enhancement of nelfinavir mesylate: in vitro characterisation and In vivo pharmacokinetic study. Mater Technol 33(12):793\u2013802. https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/10667857.2018.151131","DOI":"10.1080\/10667857.2018.1511317"},{"issue":"1","key":"3420_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2174\/2211738510666220915100150","volume":"11","author":"MS Patil","year":"2023","unstructured":"Patil MS, Shirkhedkar AA (2023) Self-microemulsifying drug delivery system for solubility and bioavailability enhancement of eprosartan mesylate: preparation, in-vitro, and in-vivo evaluation. Pharm Nanotechnol 11(1):56\u201369","journal-title":"Pharm Nanotechnol"},{"issue":"12","key":"3420_CR21","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.3390\/polym14122510","volume":"14","author":"S Perumal","year":"2022","unstructured":"Perumal S, Atchudan R, Lee W (2022) A review of polymeric micelles and their applications. Polymers (Basel) 14(12):2510. https:\/\/doi.org\/10.3390\/polym14122510","journal-title":"Polymers (Basel)"},{"key":"3420_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/J.JCONREL.2014.08.003","volume":"192","author":"LN Ramana","year":"2014","unstructured":"Ramana LN, Anand AR, Sethuraman S, Krishnan UM (2014) Targeting strategies for delivery of anti-HIV drugs. J Control Release 192:271\u2013283. https:\/\/doi.org\/10.1016\/J.JCONREL.2014.08.003","journal-title":"J Control Release"},{"key":"3420_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.msec.2016.04.089","volume":"66","author":"K Sawant","year":"2016","unstructured":"Sawant K, Pandey A, Patel S (2016) Aripiprazole loaded poly (caprolactone) nanoparticles: optimization and in vivo pharmacokinetics. Mater Sci Eng C 66:230\u2013243","journal-title":"Mater Sci Eng C"},{"key":"3420_CR24","first-page":"713","volume":"7","author":"V Saxena","year":"2012","unstructured":"Saxena V, Hussain MD (2012) Poloxamer 407\/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer. Int J Nanomedicine 7:713","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"3420_CR25","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/S11705-016-1582-2","volume":"10","author":"DH Shin","year":"2016","unstructured":"Shin DH, Tam YT, Kwon GS (2016) Polymeric micelle nanocarriers in cancer research. Front Chem Sci Eng 10(3):348\u2013359. https:\/\/doi.org\/10.1007\/S11705-016-1582-2","journal-title":"Front Chem Sci Eng"},{"issue":"1\u20132","key":"3420_CR26","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/J.IJPHARM.2012.10.024","volume":"441","author":"HM Teow","year":"2013","unstructured":"Teow HM, Zhou Z, Najlah M, Yusof SR, Abbott NJ, D\u2019Emanuele A (2013) Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier. Int J Pharm 441(1\u20132):701\u2013711. https:\/\/doi.org\/10.1016\/J.IJPHARM.2012.10.024","journal-title":"Int J Pharm"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03420-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03420-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03420-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T10:44:56Z","timestamp":1742294696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03420-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["3420"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03420-0","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"assertion":[{"value":"10 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), India. The approved protocol number was CPCSEA\/IAEC\/P-04\/2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}